Skip to the content
Know your tech before you buy it. Makers: get listed from $49/mo

CONECTA

montai.com

5.6 Club score Visit montai.com

What the maker publishes

Biology-first discovery
The platform uses a biology-first, mechanism-agnostic approach to match chemistry to desired disease activity profiles. source
Candidate timeline
Montai says it can advance hits to potent and selective oral candidates in approximately 24 months. source
Chemical library
Montai says its curated chemical space contains more than 3 billion unique compounds. source
Complex targets
The platform seeks drug discovery solutions for complex protein targets, including those with no known binding pockets. source
Data and pathways
Its multimodal foundation models are trained on more than 1 billion curated and proprietary data points and over 100 biological pathways across five therapeutic areas. source
Founded
2019 source
Headquarters
Cambridge, Massachusetts, United States source
Headquarters
Montai Therapeutics is headquartered at 26 Landsdowne Street, Cambridge, Massachusetts 02139. source
Hit rate claim
Montai reports an 80-fold higher hit rate than traditional drug screening and ninefold higher than public machine-learning models. source
Integrated expertise
The platform brings together biologists, chemists, toxicologists, CMC experts, drug developers, and machine-learning experts. source
Intended users
The platform is described as empowering drug developers to find oral solutions for difficult biology in chronic inflammatory disease. source
Partnership inquiries
Montai invites partnership inquiries by email. source
Platform access
Montai describes its website as an informational resource about the platform, rather than presenting it as a downloadable software product. source
Predictive models
The platform includes more than 60 drug-property models. source
Privacy contact
Montai lists [email protected] for privacy questions and requests. source
Purpose
CONECTA is an AI-powered drug discovery platform designed to turn underexplored natural chemistry into oral therapies. source
Scaffolds
Montai reports that 99% of its Anthromolecule library scaffolds are unique. source

Checked against the maker's pages on 14 Nov 2026.